Lensar (LNSR) Total Current Liabilities (2019 - 2026)
Lensar (LNSR) posted quarterly Total Current Liabilities of $17.8 million for Q1 2026, down 34.5% year-over-year from $27.2 million in Q1 2025, and down 56.13% quarter-over-quarter from $40.6 million in Q4 2025.
Lensar (LNSR) Total Current Liabilities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Total Current Liabilities for 8 consecutive years, with $17.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 34.5% year-over-year to $17.8 million; the TTM figure through Mar 2026 stood at $17.8 million (down 34.5% YoY), while the FY2025 annual figure was $40.6 million, up 170.44% from the prior year.
- Total Current Liabilities slipped to $17.8 million in Q1 2026 per LNSR's latest filing, from $40.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $40.6 million in Q4 2025 and bottomed at $7.8 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $16.6 million across 5 years, with a median of $11.4 million in 2022.
- Annual changes were most pronounced in 2025 — Total Current Liabilities surged 205.92% — and 2026, when it plunged 34.5%.
- Lensar's Total Current Liabilities stood at $11.4 million in 2022, then increased by 1.85% to $11.6 million in 2023, then advanced by 28.98% to $15.0 million in 2024, then soared by 170.44% to $40.6 million in 2025, then plunged by 56.13% to $17.8 million in 2026.
- Business Quant data shows LNSR's Total Current Liabilities at $17.8 million in Q1 2026, $40.6 million in Q4 2025, and $35.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Lensar | 103.79 Mn | 90.22 Mn | 9.78 Mn | 19.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.64 Mn |
| Mar 31, 2026 | 17.80 Mn |
| Dec 31, 2025 | 40.57 Mn |
| Sep 30, 2025 | 35.73 Mn |
| Jun 30, 2025 | 30.09 Mn |
| Mar 31, 2025 | 27.17 Mn |
| Dec 31, 2024 | 15.00 Mn |
| Sep 30, 2024 | 11.68 Mn |
| Jun 30, 2024 | 10.37 Mn |
| Mar 31, 2024 | 10.45 Mn |
| Dec 31, 2023 | 11.63 Mn |
| Sep 30, 2023 | 11.01 Mn |
| Jun 30, 2023 | 10.56 Mn |
| Mar 31, 2023 | 9.99 Mn |
| Dec 31, 2022 | 11.42 Mn |
| Sep 30, 2022 | 9.79 Mn |
| Jun 30, 2022 | 11.22 Mn |
| Mar 31, 2022 | 7.76 Mn |
| Dec 31, 2021 | 8.71 Mn |
| Sep 30, 2021 | 8.03 Mn |